These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2290848)

  • 21. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neurology of senile and praesenile degenerative disorders of the central nervous system].
    Erbslöh F
    Verh Dtsch Ges Pathol; 1968; 52():1-21. PubMed ID: 4182226
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nervous disease & Ca antagonist].
    Otomo E
    No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
    [No Abstract]   [Full Text] [Related]  

  • 27. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
    Steiner TJ
    Vasa Suppl; 1988; 24():44-7. PubMed ID: 3062824
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical characteristics and results in nalorphine therapy of acute cerebrovascular accidents].
    Niederland V
    Orv Hetil; 1986 May; 127(19):1119-23. PubMed ID: 3520435
    [No Abstract]   [Full Text] [Related]  

  • 30. [The aging nerve cell].
    Hervonen A
    Duodecim; 1990; 106(22):1497-500. PubMed ID: 1364682
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes for disease modifying trials.
    Wilcok G
    J Nutr Health Aging; 2007; 11(4):318-9. PubMed ID: 17653489
    [No Abstract]   [Full Text] [Related]  

  • 32. Aspects of stroke trials.
    Clifford Rose F
    Br J Clin Pract Suppl; 1985 Jun; 39():34-9. PubMed ID: 3929814
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neurotrophins. II: therapeutic potential].
    Zazpe A; Del Río J
    Rev Med Univ Navarra; 1997; 41(3):180-4. PubMed ID: 10420924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroaxonal dystrophy: an ultrastructural link between subacute spongiform virus encephalopathies and Alzheimer's disease.
    Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC
    Prog Clin Biol Res; 1989; 317():549-57. PubMed ID: 2690113
    [No Abstract]   [Full Text] [Related]  

  • 36. Important new treatments for acute ischaemic stroke?
    Sandercock P
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1224-5. PubMed ID: 3120954
    [No Abstract]   [Full Text] [Related]  

  • 37. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease.
    Lapchak PA
    Exp Neurol; 1993 Nov; 124(1):16-20. PubMed ID: 8282073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 39. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
    Unterbeck A
    Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.